Shares of Biogen BIIB gained 9.5% on Dec 29 following news on its potential acquisition by the South-Korean conglomerate Samsung Group. Per an article in The Korean Economic Daily, the U.S.-based ...
On July 17, 2025, Harrow, Inc. (“Harrow”), announced an agreement with Samsung Bioepis Co. Ltd. (“Samsung Bioepis”) to acquire the U.S. commercial rights to two of Samsung Bioepis’s biosimilars, ...
(Reuters) - Drugmaker Biogen Inc said on Thursday it would buy additional shares of Samsung Bioepis Co Ltd worth $700 million to raise its stake in the biosimilar company to 49.9 percent. Biogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results